Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04969978 · ClinicalTrials.gov registry record · NA

Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation

A NA study of Tobacco-Related Carcinoma and Smoking & Tobacco Cessation, sponsored by OHSU Knight Cancer Institute.

Active
Registry status
NA
Development phase
9,133
Enrollment target
1
Study location

NCT04969978: Active NA study of Tobacco-Related Carcinoma and Smoking & Tobacco Cessation, sponsored by OHSU Knight Cancer Institute.

NCT04969978 is a NA study of Tobacco-Related Carcinoma and Smoking & Tobacco Cessation that is active but no longer recruiting, run by OHSU Knight Cancer Institute. The registered enrollment target is 9,133 participants, above the 596-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (1432% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04969978, a NA study of Tobacco-Related Carcinoma and Smoking & Tobacco Cessation, is active but no longer recruiting, sponsored by OHSU Knight Cancer Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
9,133 participants
Enrollment target
1
Study location

Study Summary

This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also examines the cost-effectiveness of Quitline eReferrals both with and without enhanced academic detailing. If this implementation strategy is effective, this strategy could be used to increase tobacco cessation treatment through the collaboration between state Quitlines and community health centers that serve large numbers of socioeconomically disadvantaged patients who use tobacco.

Primary Outcome

Proportion of patients who accepted a Quitline eReferral in intervention (EAD) versus comparator clinics. Will use a logistic mixed effects model that addresses the following design features of the study: 1) will include random intercept for clinic to account for clustering of patients within clinics; 2) will perform an intent-to-treat analysis; 3) hypothesis tests will be two-sided.

Interventions

  • OTHER Informational Intervention
  • BEHAVIORAL Enhanced Academic Detailing

Study Locations (1)

Oregon

  • OHSU Knight Cancer Institute - Portland

Trial Details

FieldValue
Enrollment Target 9,133 participants
Start Date 2023-06-20
Est. Completion 2026-02-22
Phase NA
OHSU Knight Cancer Institute

211 total trials

What the registry record for NCT04969978 still lists

NCT04969978 is an interventional study that assigns participants to a tested intervention. Its 9,133 participants enrollment target places it among the larger protocols in the corpus, above the 596-participant average among 10 other Tobacco-Related Carcinoma trials with a reported enrollment target (1432% higher).

The record links to 2 conditions, with Tobacco-Related Carcinoma appearing as the primary indexed condition, and to 2 interventions - of which Informational Intervention is the first listed.

NCT04969978 reports a single indexed study location in Oregon.

Frequently Asked Questions

What is clinical trial NCT04969978 about?

NCT04969978 is a clinical study titled "Electronic Quitline Referral With Enhanced Academic Detailing for the Promotion of Smoking Cessation". This phase IV clinical trial determines the impact of implementing a Quitline electronic (e)Referral system with an enhanced academic detailing implementation strategy on Quitline reach, tobacco cessation assistance and self-reported quit rates among patients in community health centers. It also exa...

What is the current status of trial NCT04969978?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 9,133 participants. The study started on 2023-06-20. Estimated completion is 2026-02-22.

What conditions does trial NCT04969978 study?

This clinical trial studies the following conditions: Tobacco-Related Carcinoma, Smoking & Tobacco Cessation.

What interventions are being tested in trial NCT04969978?

The interventions under investigation include: Informational Intervention (OTHER), Enhanced Academic Detailing (BEHAVIORAL).

Who is sponsoring clinical trial NCT04969978?

This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04969978 being conducted?

This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tobacco-Related Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04969978's enrollment target sits among peer trials

9,133 1st of 10 higher than 10 of 10 other Tobacco-Related Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Tobacco-Related Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06946355 · 9,119 participants · NA

    Food-based Support for Hospitalized Children and Their Families

  • NCT02000089 · 9,000 participants · Phase 3

    The Cancer of the Pancreas Screening-5 CAPS5)Study

  • NCT05612347 · 8,946 participants · NA

    Colonoscopy vs Stool Testing for Older Adults With Colon Polyps

  • NCT06284408 · 9,460 participants · NA

    Centralized Screening Unit (CSU) at Montefiore-Einstein

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04969978, the US trial registry maintained by the National Library of Medicine. NCT04969978 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.